In DepthInfectious Disease

Scandal clouds China's global vaccine ambitions

See allHide authors and affiliations

Science  29 Apr 2016:
Vol. 352, Issue 6285, pp. 506
DOI: 10.1126/science.352.6285.506

You are currently viewing the summary.

View Full Text


Health experts hail two new Chinese-made vaccines against hand, foot, and mouth disease as a milestone against a malady that has run rampant in China. But that triumph was overshadowed by a safety crisis involving other homegrown vaccines. In recent weeks, police have arrested more than 200 people in connection with the nationwide distribution of 2 million doses of expired Chinese-made vaccines against scourges such as hepatitis B and rabies. No adverse reactions have been confirmed. China's vaccine developers hope the debacle won't derail efforts to make inroads into the global $33 billion vaccine market. But without a major overhaul, China's vaccine system might not recover quickly.

  • * in Beijing